Inhibitors of alanine racemase enzyme: a review

Abstract

Alanine racemase is a fold type III PLP-dependent amino acid racemase enzyme catalysing the conversion of l-alanine to d-alanine utilised by bacterial cell wall for peptidoglycan synthesis. As there are no known homologs in humans, it is considered as an excellent antibacterial drug target. The standard inhibitors of this enzyme include O-carbamyl-d-serine, d-cycloserine, chlorovinyl glycine, alafosfalin, etc. d-Cycloserine is indicated for pulmonary and extra pulmonary tuberculosis but therapeutic use of drug is limited due to its severe toxic effects. Toxic effects due to off-target affinities of cycloserine and other substrate analogs have prompted new research efforts to identify alanine racemase inhibitors that are not substrate analogs. In this review, an updated status of known inhibitors of alanine racemase enzyme has been provided which will serve as a rich source of structural information and will be helpful in generating selective and potent inhibitor of alanine racemase.

• Alanine racemase
• antibacterial activity
• cycloserine
• d-alanine
• pyridoxal 5′-phosphate

View correction statement:

Correction to: Inhibitors of alanine racemase enzyme: a review

Declaration of interest

The authors report that they have no conflicts of interest. We would like to thank University Grants Commission (UGC), Government of India, for the financial support (No. F1-17.1/2014-15/RGNF-2014-15-SC-KER-61880).